Application and comparison of different implanted ports in malignant tumor patients

Yanhong Li(Guilin University of Technology), Yanhong Deng(Sun Yat-sen University), Xinmei Ye(Sun Yat-sen University), Jiayu Ling(Sun Yat-sen University), Meijin Huang(Sun Yat-sen University), Liang Kang(Sun Yat-sen University), Jianwei Zhang(Capital Medical University), Xingwei Zhang(Affiliated Hospital of Hangzhou Normal University), Yonghua Cai(Sun Yat-sen University), Xiaoqin Gan(University of Electronic Science and Technology of China), Huabin Hu(Sun Yat-sen University), Yue Cai(Sun Yat-sen University), Junwen Ye(Sun Yat-sen University)
World Journal of Surgical Oncology
September 23, 2016
10.1186/s12957-016-1002-6
Cited by 19

Related Papers

RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410